Delivery Order SPE2DB20D2104-SPE2DB24FT57Q
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Vemlidy 25 mg tablets. The $34,970.40 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Vemlidy 25 mg tablets. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $7,866.04 and a completion date of November 13, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as a primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Vemlidy 25 mg tablets. The contract, valued at $10,975.25, is a Delivery Order with a Firm Fixed Price pricing type. The contract has an ultimate completion date of August 27, 2024. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including military treatment facilities and veterans' hospitals. This...
- This federal contract award is for the delivery of Vemlidy 25 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $6,633.21 and a period of performance through July 12, 2023. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of Vemlidy 25 mg tablets. The award has a ceiling value of $5,496.19 and a period of performance through April 2, 2024. This is a firm fixed price delivery order contract, with no set-aside designation used. Amerisourcebergen Drug Corp, based in Conshohocken, Pennsylvania, is the prime contractor and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $67,792.74 firm-fixed-price delivery order is for the supply of Vemlidy 25 mg tablets to support military healthcare needs. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen's parent company, Cencora, Inc., holds with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $17,284.07, is for the delivery of Vemlidy 25 mg tablets. The contract is a Firm Fixed Price Delivery Order with a completion date of December 5, 2023. There is no set-aside designation for this award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award to Amerisourcebergen Drug Corp., a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the provision of Vemlidy 25 mg tablets. The contract is a Delivery Order with a Firm Fixed Price type, valued at $2,858.01, and has an ultimate completion date of January 31, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This federal contract award is for the delivery of Vemlidy 25 mg tablets to support medical needs. The contract, valued at $26,370.75, was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 24, 2022. The award is a delivery order placed under AmerisourceBergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 4,560,986,576 units of the drug Vemlidy 25 mg tablet. The contract has a ceiling value of $5,474.28 and a completion date of May 19, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which is the parent company. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Cencora, Inc. holds...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FT57QDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Vemlidy 25 mg tablets. The contract has a ceiling value of $3,766.21 and a period of performance through April 12, 2024. It is a firm-fixed-price delivery order contract, with no set-aside designation indicated. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has extensive experience providing pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense and Department of Veterans Affairs healthcare systems. This contract award is likely part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as a primary vehicle for the company to deliver a comprehensive range of essential medical commodities to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 4/11/24 |